Shares of Diploma PLC (LON:DPLM – Get Free Report) have received an average rating of “Moderate Buy” from the eight research firms that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12 month target price among brokers that have covered the stock in the last year is GBX 7,400.
Several research analysts have recently issued reports on DPLM shares. Deutsche Bank Aktiengesellschaft upped their target price on shares of Diploma from GBX 6,400 to GBX 7,200 and gave the stock a “buy” rating in a research note on Wednesday, May 20th. JPMorgan Chase & Co. boosted their price objective on shares of Diploma from GBX 5,760 to GBX 8,250 and gave the stock an “overweight” rating in a report on Monday, August 24th. Berenberg Bank reaffirmed a “buy” rating and issued a GBX 9,000 price objective on shares of Diploma in a research report on Monday, July 20th. Royal Bank Of Canada increased their target price on Diploma from GBX 7,300 to GBX 7,400 and gave the company an “outperform” rating in a research note on Friday, July 17th. Finally, Jefferies Financial Group reissued a “hold” rating and issued a GBX 7,000 target price on shares of Diploma in a report on Friday, May 29th.
Get Our Latest Research Report on DPLM
Insider Activity at Diploma
Diploma Price Performance
DPLM opened at GBX 7,330 on Monday. The firm has a market cap of £9.83 billion, a PE ratio of 52.06, a P/E/G ratio of 2.82 and a beta of 0.92. The stock has a 50-day moving average price of GBX 7,248.83 and a 200-day moving average price of GBX 6,644.87. Diploma has a 1 year low of GBX 4,970 and a 1 year high of GBX 7,765. The company has a debt-to-equity ratio of 47.65, a current ratio of 2.06 and a quick ratio of 0.80.
Diploma Company Profile
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Featured Stories
- Five stocks we like better than Diploma
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
